cccc-20240429
0001662579DEFA14AFALSE00016625792022-01-012022-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.    )
_____________________
Filed by the Registrant  x                                 Filed by a Party other than the Registrant  o
Check the appropriate box:
oPreliminary Proxy Statement
oConfidential, for Use of the Commission Only (as permitted by Rule 14a6(e)(2))
o
Definitive Proxy Statement
xDefinitive Additional Materials
o
Soliciting Material Pursuant to §240.14a12
C4 THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check boxes that apply):
xNo fee required.
o
Fee paid previously with preliminary materials.
o
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 011.




https://cdn.kscope.io/a0d5479e58c1f6c8f5763d5dadd0997a-Capture.jpg



https://cdn.kscope.io/a0d5479e58c1f6c8f5763d5dadd0997a-Capture1.jpg